ATE1044T1 - Impfstoff gegen infektioese peritonitis der feliden und verfahren zu seiner herstellung. - Google Patents

Impfstoff gegen infektioese peritonitis der feliden und verfahren zu seiner herstellung.

Info

Publication number
ATE1044T1
ATE1044T1 AT79104764T AT79104764T ATE1044T1 AT E1044 T1 ATE1044 T1 AT E1044T1 AT 79104764 T AT79104764 T AT 79104764T AT 79104764 T AT79104764 T AT 79104764T AT E1044 T1 ATE1044 T1 AT E1044T1
Authority
AT
Austria
Prior art keywords
infectious peritonitis
virus
felids
production
felix
Prior art date
Application number
AT79104764T
Other languages
English (en)
Inventor
Bernard Fishman
Kevin Joseph O'reilly
Louise Mary Hitchcock
Original Assignee
The Wellcome Foundation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Wellcome Foundation Limited filed Critical The Wellcome Foundation Limited
Application granted granted Critical
Publication of ATE1044T1 publication Critical patent/ATE1044T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT79104764T 1978-11-30 1979-11-29 Impfstoff gegen infektioese peritonitis der feliden und verfahren zu seiner herstellung. ATE1044T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7846666 1978-11-30
EP19790104764 EP0011865B1 (de) 1978-11-30 1979-11-29 Impfstoff gegen infektiöse Peritonitis der Feliden und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
ATE1044T1 true ATE1044T1 (de) 1982-06-15

Family

ID=10501438

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79104764T ATE1044T1 (de) 1978-11-30 1979-11-29 Impfstoff gegen infektioese peritonitis der feliden und verfahren zu seiner herstellung.

Country Status (10)

Country Link
EP (1) EP0011865B1 (de)
JP (1) JPS5576820A (de)
AT (1) ATE1044T1 (de)
AU (1) AU5329179A (de)
DE (1) DE2962921D1 (de)
DK (1) DK506979A (de)
ES (1) ES8107024A1 (de)
HU (1) HU181994B (de)
NZ (1) NZ192271A (de)
ZA (1) ZA796477B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
CA1303500C (en) * 1986-02-06 1992-06-16 Charles A. Baldwin Feline infectious peritonitis vaccine
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
CA2011025A1 (en) * 1989-03-01 1990-09-01 Terry R. Beardsley Feline infectious peritonitis vaccine
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1177635A (en) * 1966-02-18 1970-01-14 Wellcome Found Cell Stains.
GB1286250A (en) * 1968-10-08 1972-08-23 Wellcome Found Heteroploid cell lines
GB1471262A (en) * 1974-03-25 1977-04-21 C Vet Ltd Virus growth
GB1492930A (en) * 1974-10-31 1977-11-23 Afg Ltd Virus growth

Also Published As

Publication number Publication date
EP0011865A1 (de) 1980-06-11
ES486441A0 (es) 1980-12-16
JPS5576820A (en) 1980-06-10
HU181994B (en) 1983-11-28
DE2962921D1 (en) 1982-07-08
NZ192271A (en) 1983-03-15
ES8107024A1 (es) 1980-12-16
EP0011865B1 (de) 1982-05-19
ZA796477B (en) 1981-07-29
AU5329179A (en) 1980-06-05
DK506979A (da) 1980-05-31

Similar Documents

Publication Publication Date Title
KR900001382A (ko) 연속 셀라인에서의 ibdv생성
ATE2014T1 (de) Lebendes, attenuiertes virus des hepatitis a beim menschen, verfahren zu seiner zuechtung in zellkultur in vitro und dieses virus enthaltende zusammensetzung.
ATE7855T1 (de) Herstellung von virusantigenen.
ATE19591T1 (de) Virus der infektioesen katzen-bauchfellentzuendung, seine herstellung und es enthaltende vakzine.
GB1183506A (en) New vaccines for combating influenza and the preparation thereof
ES486442A0 (es) Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
GB1522006A (en) Feline calicivirus vaccine and a process for the production thereof
ATE1044T1 (de) Impfstoff gegen infektioese peritonitis der feliden und verfahren zu seiner herstellung.
EP0019218A3 (en) Influenza virus vaccines, process for preparing them, process for propagating influenza viruses and cell culture inoculated with influenza virus
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
ES432385A1 (es) Un metodo de obtener una cepa de virus de la gripe.
AU6258480A (en) Prep" of influenza virus strains and vaccines
KR880001808A (ko) 닭의 전염병(전염성 후두기관염 및 마렉크병) 생 왁진
GB1462545A (en) Feline rhinotracheitis vaccine and production thereof
RU2078817C1 (ru) Аттенурованный холодоадаптированный штамм вируса гриппа, используемый для получения живой интраназальной гриппозной вакцины
GB1270918A (en) Preparation of multivalent vaccines
Parkman et al. Development and characterization of a live attenuated rubella virus
GB1498821A (en) Vaccines
AR212170A1 (es) Medio de cultivo de celulas para la produccion de virus utilizables en la elaboracion de vacunas y un procedimiento para la preparacion de una vacuna mediante dicho medio de cultivo
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza
FR2290220A2 (fr) Nouveau vaccin antirabique
GB1338043A (en) Process for producing virus cultures and vaccines
NL7506620A (en) Cell-free chickenpox virus prodn - for vaccines, by passing on human or monkey cells until attenuated then recovering the virus in presence of a stabiliser
RU99113870A (ru) Вакцинный штамм вируса краснухи "орлов-д" и способ получения вакцины против краснухи
Wu Studies on the Cultivation of Human Diploid Cells in Microcarrier Culture.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee